63.48
63.48 (0%)
As of Dec 17, 2024
Catalent, Inc. [CTLT]
Source:
Company Overview
Catalent, Inc. provide differentiated development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products at approximately fifty facilities across four continents under rigorous quality and operational standards.
| Country | United States |
| Headquarters | somerset, new jersey |
| Phone Number | (732) 537-6200 |
| Industry | manufacturing |
| CEO | Alessandro Maselli |
| Website | catalent.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $4,381 |
| Operating Profit | $-749 |
| Net Income | $-1,043 |
| Net Cash | $9 |
Profit Ratios
| Gross Margin | $953 |
| Operating Margin | -17.1 |
| Profit as % of Revenues | -91.4% |
| Profit as % of Assets | -14.8% |
| Profit as % of Stockholder Equity | -28.9% |
Management Effectiveness
| Return on Equity | -28.9% |
| Return on Assets | -10.7% |
| Turnover Ratio | 62% |
| EBITA | $-749 |
Balance Sheet and Cash Flow Measures
| Total Assets | $9,753 |
| Total Liabilities | $6,149 |
| Operating Cash Flow | $268 |
| Investing Cash Flow | $-327 |
| Financing Cash Flow | $74 |
